Zimmer Wins Genzyme Trial Over Knee-Arthritis Treatment

Zimmer Holdings Inc. and Seikagaku Corp. won a U.S. patent-infringement trial brought by Sanofi’s Genzyme over a treatment for arthritis in the knee.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.